In last trading session, Cogent Biosciences Inc (NASDAQ:COGT) saw 0.99 million shares changing hands with its beta currently measuring 1.52. Company’s recent per share price level of $6.67 trading at -$0.16 or -2.34% at ring of the bell on the day assigns it a market valuation of $693.08M. That closing price of COGT’s stock is at a discount of -102.4% from its 52-week high price of $13.50 and is indicating a premium of 44.98% from its 52-week low price of $3.67. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.92 million shares which gives us an average trading volume of 2.22 million if we extend that period to 3-months.
Cogent Biosciences Inc (NASDAQ:COGT) trade information
Upright in the red during last session for losing -2.34%, in the last five days COGT remained trading in the green while hitting it’s week-highest on Friday, 03/15/24 when the stock touched $6.67 price level, adding 9.62% to its value on the day. Cogent Biosciences Inc’s shares saw a change of 13.44% in year-to-date performance and have moved 1.99% in past 5-day. Cogent Biosciences Inc (NASDAQ:COGT) showed a performance of -22.08% in past 30-days. Number of shares sold short was 9.07 million shares which calculate 2.83 days to cover the short interests.
Cogent Biosciences Inc (COGT) estimates and forecasts
Statistics highlight that Cogent Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -33.10% of value to its shares in past 6 months, showing an annual growth rate of 22.73% while that of industry is 12.10. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 5.60% in the current quarter and calculating 16.90% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 15.33% during past 5 years.
COGT Dividends
Cogent Biosciences Inc is more likely to be releasing its next quarterly report between May 07 and May 13 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Cogent Biosciences Inc (NASDAQ:COGT)’s Major holders
Insiders are in possession of 0.13% of company’s total shares while institution are holding 92.00 percent of that, with stock having share float percentage of 92.12%. Investors also watch the number of corporate investors in a company very closely, which is 92.00% institutions for Cogent Biosciences Inc that are currently holding shares of the company. RA Capital Management, L.P. is the top institutional holder at COGT for having 6.42 million shares of worth $75.97 million. And as of Jun 29, 2023, it was holding 7.51% of the company’s outstanding shares.
The second largest institutional holder is Tcg Crossover Management, Llc, which was holding about 5.63 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 6.59% of outstanding shares, having a total worth of $66.67 million.
On the other hand, Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 3.44 million shares of worth $40.74 million or 4.03% of the total outstanding shares. The later fund manager was in possession of 2.47 million shares on Jun 29, 2023, making its stake of worth around $29.25 million in the company or a holder of 2.89% of company’s stock.
